Bioceltix S.A. (WSE: BCX)
Poland flag Poland · Delayed Price · Currency is PLN
74.20
+0.20 (0.27%)
Nov 20, 2024, 5:00 PM CET

Bioceltix Ratios and Metrics

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21
Market Capitalization
363372133172
Market Cap Growth
15.76%179.48%-22.49%-
Enterprise Value
344357130-
Last Close Price
73.8090.0038.8052.20
PB Ratio
8.1035.5125.8228.60
P/TBV Ratio
7.0035.5125.8228.60
Debt / Equity Ratio
0.000.020.060.09
Quick Ratio
3.265.231.943.41
Current Ratio
7.215.242.683.42
Return on Equity (ROE)
-50.19%-175.28%-160.02%-
Return on Assets (ROA)
-28.03%-85.92%-70.62%-
Return on Capital (ROIC)
-31.71%-108.90%-93.47%-
Earnings Yield
-5.15%-3.68%-6.71%-2.56%
FCF Yield
-3.81%-4.09%-6.19%-2.35%
Buyback Yield / Dilution
-16.64%-17.48%-5.54%-
Total Shareholder Return
-16.64%-17.48%-5.54%-
Source: S&P Capital IQ. Standard template. Financial Sources.